Liver transplantation in the era of cost constraints

Southern Medical Journal

Volumn 93, Issue 4, 2000, Pages 392-396

  Eckhoff, Devin E ^a   McGuire, Brendan M ^b   Young, Carlton ^b   Sellers, Marty T ^b   Contreras, Juan L ^b   Frenette, Luc R ^b   Hudson, Sharon L ^b   Bynon, J Stevenson ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; ARTICLE; COST CONTROL; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OUTPATIENT CARE;

EID: 0034054871     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200004000-00008     Document Type: Article

References (13)

1. Williams JW, Vera SR, Peters TG, et al: Survival following hepatic transplantation in the cyclosporine era. Am Surg 1986; 52:291-293
2. Klopmaker IJ, Haagsina EB, Gouw AS, et al: Azathioprine and prednisone immunosuppression versus maintenance triple therapy including cyclosporine for orthotopic liver transplantation. Transplantation 1989; 48:814-818
3. Powell-Jackson P, Polson RJ, Williams R: Post-operative management in liver transplantation. Liver Transplantation. Caine RY (ed). Orlando, Fla, Grune & Stratton, 2nd Ed, 1987, pp 253-261
4. Starzl TE: Liver transplantation. Hepatic Transplantation. Winter PM, Kang YG (eds). New York, Praeger Scientific, 1986, pp 3-18
5. Kankaanpaa J: Cost-effectiveness of liver transplantation - how to apply the results in resource allocation. Prev Med 1990; 19:700-704
6. Evans RW: Liver transplantation in managed care environment. Liver Transplant Surg 1995; 1:61-75
7. Kim WR, Therneau TM, Dickson ER, et al: Preoperative predictors of resource utilization in liver transplantation. Clin Transpl 1995; 27:315-322
8. 1994 Annual Report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network. Transplant Data: 1988-1993. Richmond, VA, UNOS, and Bethesda, Md, Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, US Department of Health and Human Services
9. Cecka J, Terasaki P: Clinical Transplants 1997. Los Angeles, Calif, UCLA Tissue Typing Laboratory, 1998, pp 541-557
10. Sonnefeld ST, Waldo DR, Lemieux JA, et al: Projections of national health expenditures through the year 2000. Health Care Fin Rev 1991; 13:1-27
11. Evans RW, Kitzmann BA: Contracting for services: liver transplantation in the era of mismanaged care. Clin Liver Dis 1997; 1:287-303
12. Evans R: Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. Clin Transpl 1993; 34:359-386
13. Reemtsma K, Berland G, Merrill J, et al: Evaluation of surgical procedures, changing patterns of patient selection and costs in heart transplantation. J Thorac Cardiovasc Surg 1992; 104:1308-1313